FDA approves Pfizer booster for 65 and older, others at high risk

Name: FDA approves Pfizer booster for 65 and older, others at high risk
Uploaded: 2021-09-23T16:03:38+00:00
Duration: 46 s
Description: The U.S. Food and Drug Administration agreed with a government advisory panel and approved the Pfizer-BioNTech COVID-19 vaccine booster for those who are 65 years and older or run a high risk of severe disease.

The U.S. Food and Drug Administration agreed with a government advisory panel and approved the Pfizer-BioNTech COVID-19 vaccine booster for those who are 65 years and older or run a high risk of severe disease.

Posted September 23, 2021 9:03am PDT